|
First mRNA Dose Reaction Doesn’t Automatically Bar Second Dose
|
|
One of the issues that has remained unclear since the first COVID-19 vaccine doses became available earlier this year is the appropriate protocol for recipients showing signs of an allergic reaction. A new study suggests that what looks like an allergic response might not actually be one, and that many—if not most—of those patients can receive a second dose with some premedication.
|
|
|
Are ARBs Better Than ACE Inhibitors for Patients Initiating
BP Medication?
|
|
|
Practice guidelines recommend both angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) for patients newly prescribed blood-pressure (BP) medication. A new study finds that, while the two types of medications work equally well, their side-effect profiles are different. Find out why the authors recommend ARBs as first-line therapy over ACE inhibitors.
|
|
Retail Pharmacist–Administered COVID-19 Vaccine Doses Exceed
110 Million
|
|
|
Pharmacists have administered a lot of shots to help protect Americans against COVID-19—more than 112 million. Not only did availability of the shots at pharmacies save many lives, but one pharmacy organization argues that the role played by pharmacists might have changed the nation’s view of their abilities for the better. Here is more information.
|
|
|
Shorter Antibiotic Duration for Male UTI Treatment Works As Well as Longer Treatment
|
|
Sometimes less is more, and that seems to be the case with antibiotics for urinary tract infections where patients aren’t feverish. A new study found that a shorter duration of ciprofloxacin or trimethoprim/sulfamethoxazole works as well—if not even better—than a longer one in male urinary tract infections. Here is more information.
|
|
